GH Research PLC (GHRS)
10.98
-0.38
(-3.30%)
USD |
NASDAQ |
Apr 24, 15:14
GH Research Cash from Financing (TTM): -0.204M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.204M |
| September 30, 2023 | -0.163M |
| June 30, 2023 | -0.107M |
| March 31, 2023 | -0.07M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.00 |
| September 30, 2022 | -0.171M |
| June 30, 2022 | -2.773M |
| March 31, 2022 | 286.45M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.773M
Minimum
Jun 2022
286.45M
Maximum
Mar 2022
35.37M
Average
-0.135M
Median
Cash from Financing (TTM) Benchmarks
| Amarin Corp PLC | 0.23M |
| Jazz Pharmaceuticals PLC | -305.25M |
| Prothena Corp PLC | 45.10M |
| Iterum Therapeutics PLC | 1.034M |
| Mural Oncology PLC | -- |